Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
Abstract
This contract will provide support for the ongoing survey of chemical and biological information for potential therapeutic compounds for HIV, tuberculosis (TB), hepatitis B virus (HBV). The resulting information and associated analytical tools are critical for the rational selection and discovery of potential therapies for HIV, TB, and HBV.
Key facts
- NIH application ID
- 10629145
- Project number
- 75N93020C00031-P00003-9999-1
- Recipient
- GRYPHON SCIENTIFIC, LLC
- Principal Investigator
- LOUISE SUMNER
- Activity code
- N01
- Funding institute
- NIH
- Fiscal year
- 2022
- Award amount
- $802,459
- Award type
- —
- Project period
- 2021-09-30 → 2022-09-29